Elisabeth Leiderman

CIK: 0001842133

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AUTL

Autolus Therapeutics plc

Director

BLUE

bluebird bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

AUTL
Autolus Therapeutics plc
Jun 29, 2026
Award(A)
Restricted Share Units
Direct
31.7K shares-
AUTL
Autolus Therapeutics plc
Jun 29, 2026
Award(A)
Share Option (Right to Buy)
Direct
47.5K shares-
BLUE
bluebird bio, Inc.
Jun 2, 2025
Disposition(D)
Direct
1.2K shares-
BLUE
bluebird bio, Inc.
May 30, 2025
Tender Offer(U)
Direct
1.1K shares-
BLUE
bluebird bio, Inc.
Nov 6, 2024
Award(A)
Direct
24.9K shares-

		Type	Shares	Price		Ownership
Jun 29, 2026	AUTL Autolus Therapeutics plc	Award(A) Restricted Share Units	31,667	-	-	Direct
Jun 29, 2026	AUTL Autolus Therapeutics plc	Award(A) Share Option (Right to Buy)	47,500	-	-	Direct
Jun 2, 2025	BLUE bluebird bio, Inc.	Disposition(D)	1,245	-	-	Direct
May 30, 2025	BLUE bluebird bio, Inc.	Tender Offer(U)	1,112	-	-	Direct
Nov 6, 2024	BLUE bluebird bio, Inc.	Award(A)	24,900	-	$0	Direct

1-5 of 5 transactions

About Leiderman Elisabeth

Leiderman Elisabeth (SEC CIK 0001842133) files insider reports with the SEC as Director of Autolus Therapeutics plc (AUTL) and Director of bluebird bio, Inc. (BLUE).

Signal8 holds 4 ownership filings by Leiderman Elisabeth (1 Form 3, 3 Form 4), filed between Nov 8, 2024 and Jul 1, 2026. Those filings report 5 transactions, from Nov 6, 2024 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Leiderman Elisabeth's filings is in LONDON.

Recent filings by Leiderman Elisabeth

Jun 29, 2026: Grants or awards of AUTL derivative securities (2 lines, Form 4, code A).
Jun 2, 2025: Disposition to issuer transaction of BLUE shares (Form 4, code D).
May 30, 2025: Tender of shares transaction of BLUE shares (Form 4, code U).
Nov 6, 2024: Grant or award of BLUE shares (Form 4, code A).

Other insiders filing for Autolus Therapeutics plc (AUTL)

Piccina Cintia, U.S. CCO & Country Gen Manager
YOUNG WILLIAM D, Director
Rao Madduri Ravin, Director
Richardson Ryan, Director
Iannone Robert, Director
BUTITTA CYNTHIA M, Director

How to read Form 4 transaction codes